Constellation Pharmaceuticals to Host Conference Call to Discuss First Quarter 2021 Results
27 Avril 2021 - 5:30PM
Constellation Pharmaceuticals, Inc., a clinical-stage
biopharmaceutical company using its expertise in epigenetics to
discover and develop novel therapeutics, will host a conference
call at 8:00 AM EDT on May 10, 2021, to discuss its first quarter
2021 results and provide a business update. The event will be
webcast live and can be accessed on the Investor Relations section
of Constellation’s website at
http://ir.constellationpharma.com/events-and-presentations/events.
To participate in the live question-and-answer session, please dial
(877) 473-2077 (domestic) or (661) 378-9662 (international) and
refer to conference ID 8798968.
About Constellation Pharmaceuticals
Constellation Pharmaceuticals is a clinical-stage
biopharmaceutical company developing novel therapeutics that
selectively modulate gene expression to address serious unmet
medical needs in patients with cancer. The Company has a deep
understanding of how epigenetic and chromatin modifications in
cancer cells and in the tumor and immune microenvironment play a
fundamental role in driving disease progression and drug
resistance. Constellation is driving development of the BET
inhibitor pelabresib (CPI-0610) for the treatment of myelofibrosis
as well as its EZH2 inhibitor CPI-0209 for the treatment of other
cancers. The Company is also applying its broad research and
development capabilities to explore other novel targets that
directly and indirectly impact gene expression to fuel a
sustainable pipeline of innovative small-molecule product
candidates.
Contacts
Kia Khaleghpour, PhDVice President, Investor Relations and
CommunicationsConstellation Pharmaceuticals+1
617-844-6859kia.khaleghpour@constellationpharma.com
Lauren ArnoldMedia RelationsMacDougall Biomedical
Communications+1 781-235-3060larnold@macbiocom.com
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024
Real-Time news about Constellation Pharmaceuticals Inc (NASDAQ): 0 recent articles
Plus d'articles sur